As of November 2024, GeneReach Biotechnology has a market cap of $57.58M. This makes GeneReach Biotechnology the world's 24395th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $68.27M | -3.68% |
2023 | $70.87M | -40.23% |
2022 | $118.57M | -27.31% |
2021 | $163.12M | -27.82% |
2020 | $225.98M | 91.85% |
2019 | $117.79M | 74.87% |
2018 | $67.36M | 96.94% |
2017 | $34.20M | -2.00% |
2016 | $34.90M | -37.11% |
2015 | $55.49M | -41.33% |
2014 | $94.58M | 20.44% |
2013 | $78.53M | 0.00% |
2012 | $78.53M | - |